For the Inventor, By the Inventor

Enter assignee name

London, United Kingdom

James Black Foundation Limited

USPTO Granted Patents = 20

% Expired Patents = 25.0

Forward Citations = 180

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

Sarkis Barret Kalindjian (16 out of 22 patents)

Iain Mair McDonald (13 out of 13 patents)

Ildiko Maria Buck (10 out of 32 patents)

4. Matthew John Tozer (9 out of 9 patents)

5. Michael John Pether (9 out of 9 patents)

6. Caroline M Low (8 out of 8 patents)

7. Nigel Paul Shankley (7 out of 7 patents)

8. David John Dunstone (7 out of 7 patents)

9. Katherine Isobel Steel (6 out of 6 patents)

10. Ian Duncan Linney (5 out of 5 patents)

11. Elaine Anne Harper (5 out of 5 patents)

12. Jonathan Michael Davies (5 out of 5 patents)

13. Caroline Minli Rachel Low (4 out of 6 patents)

14. Robert A Hull (4 out of 4 patents)

15. Katherine Isobel Mary Steel (3 out of 3 patents)

20 patents: Sort by Forward Citations

1. 7105558 - Gastrin and cholecystokinin receptor lignads (iv) (2006-09-12),

2. 7034048 - Gastrin and cholecystokinin receptor ligands (III) (2006-04-25),

3. 6956053 - Pyrazole derivatives and their use as gastrin and cholecystokin receptor ligands (2005-10-18),

4. 6878736 - Histamine H3 receptor ligands (2005-04-12),

5. 6878734 - Gastrin and cholecystokinin receptor ligands(II) (2005-04-12),

6. 6479531 - Gastrin and cholecystokinin receptor ligands (2002-11-12),

7. 6407132 - Substituted imidazole derivatives and their use as histamine H3 receptor ligands (2002-06-18),

8. 6355665 - 1H-4(5)-substituted imidazole derivatives, their preparation and their use as histamine H3 receptor ligands (2002-03-12),

9. 6159994 - Histamine H.sub.3 receptor ligands (2000-12-12),

10. 6080871 - Sulfonamides and sulfamides as H.sub.3 receptor antagonists (2000-06-27),

11. 6057311 - Benzodiazonine derivatives binding to cholecystokinin or gastrin (2000-05-02),

12. 5939437 - CCK and gastrin receptor ligands (1999-08-17),

13. 5919829 - Gastrin and cck receptor ligands (1999-07-06),

14. 5912260 - Gastrin and CCK antagonists (1999-06-15),

15. 5847125 - Amino acid derivatives with anticholecystokinin activity (1998-12-08),

Company Overview

James Black Foundation Limited is a research organization based in London, specializing in the development of innovative therapeutic solutions. The foundation focuses on advancing medical research, particularly in the fields of drug discovery and development. By fostering collaboration among scientists and industry experts, it aims to translate scientific breakthroughs into effective treatments. The foundation is committed to enhancing healthcare outcomes through its dedication to pioneering research and technology in the biomedical sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

20 Patents

#188 in London

#890 in United Kingdom

#31,295 in the World

London, United Kingdom

James Black Foundation Limited

Forward Citations = 180

34 inventors:

Sarkis Barret Kalindjian (16 out of 22 patents)

Iain Mair McDonald (13 out of 13 patents)

Ildiko Maria Buck (10 out of 32 patents)

4. Matthew John Tozer (9 out of 9 patents)

5. Michael John Pether (9 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: James Black Foundation Limited. Retrieved from https://idiyas.com/company/james-black-foundation

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…